CareDx (CDNA) has had the highest return since March 27, 2026 by a mid-cap US stock, returning 404.1%.
| ASSET | % RETURN |
|---|---|
CareDx (CDNA) | 404.09% |
MaxLinear (MXL) | 299.47% |
Absci (ABSI) | 291.9% |
Abcellera Biologics (ABCL) | 270.69% |
10X Genomics (TXG) | 249.33% |
AMC Entertainment (AMC) | 215.46% |
Penguin Solutions (PENG) | 198.45% |
Porch (PRCH) | 187.55% |
Hinge Health (HNGE) | 185.8% |
Tenable (TENB) | 184.79% |
GRAIL, LLC (GRAL) | 181.24% |
Gitlab (GTLB) | 160.05% |
Amplitude (AMPL) | 159.97% |
BlackBerry (BB) | 159.08% |
Oscar Health (OSCR) | 158.91% |
Maravai Lifesciences Holdings (MRVI) | 155.23% |
Qualys (QLYS) | 152.87% |
Insight Enterprises (NSIT) | 150.93% |
Clover Health Investments (CLOV) | 149.16% |
Five9 (FIVN) | 145.87% |
Xencor (XNCR) | 145.03% |
Pulse Biosciences (PLSE) | 141.85% |
Kodiak Sciences (KOD) | 136.76% |
Okeanis Eco Tankers (ECO) | 136.29% |
Schrodinger (SDGR) | 136% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.